As the Centers for Medicare & Medicaid Services adjust regulations for the upcoming fiscal cycle, beneficiaries face a shifting landscape in healthcare expenses that alters how monthly budgets are ...

Medicare coverage of targeted disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA) -- both under Medicare Advantage and in separate Part D plans -- is likely to leave many ...

Starting Jan. 1, 2025, millions of Americans who get their prescription drugs through Medicare could get a major financial break when a $2,000 out-of-pocket spending cap on medications goes into ...

Successful formulary system management can help ACOs achieve high quality, low cost objectives across the care continuum. This article targets healthcare leaders choosing to participate in the ...

Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management. Objectives: To evaluate the appropriateness ...

Are Weight Loss Drugs Covered By Insurance? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re considering using medication to reach a healthy body weight, your first question ...

Insurance companies don't cover some medications, which often leaves consumers responsible for the full costs. If your prescription is not covered, you can try generics, biosimilars, or other ...

Prescription drug prices are a major concern for people, healthcare professionals, and policymakers. Even for those with insurance, out-of-pocket costs can still be high. Several factors contribute to ...

Postdischarge adverse drug event risk is amplified by frequent medication changes, formulary substitutions, and insurance coverage gaps, with wide variability in published incidence estimates and ...